Stock ANGO ANGIODYNAMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
5.89 USD -4.07% Intraday chart for AngioDynamics, Inc. +1.73% -24.87%
May. 06 AngioDynamics, Inc. Announces Results from the Acute Pulmonary Embolism Extraction Trial with the Alphavac System (APEX-AV) CI
Apr. 08 North American Morning Briefing : Inflation Data, -2- DJ

Evolution of the average Target Price on AngioDynamics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b0e4.Yw8W4OVRlS1iqU53iOojdEul60qF3Y3jP7BF5hdzwMU.DkZhj4M9oB0L0xcazJp6TGb3vH2w68CqetEBo3JKl6BRYlqX0CH8fQ3Mfg~734aa923f3c6aacbca620da8a866b69c

Analyst Recommendations on AngioDynamics, Inc.

Oppenheimer Upgrades AngioDynamics to Outperform From Perform, $12 Price Target MT
Raymond James Adjusts Price Target on AngioDynamics to $10 From $12, Maintains Outperform Rating MT
HC Wainwright Adjusts Price Target on AngioDynamics to $18 From $20, Keeps Buy Rating MT
Raymond James Adjusts Price Target on AngioDynamics to $12 From $13, Keeps Outperform Rating MT
HC Wainwright Adjusts AngioDynamics' Price Target to $20 From $19, Keeps Buy Rating MT
HC Wainwright Starts AngioDynamics at Buy With $19 Price Target MT
Canaccord Genuity Adjusts AngioDynamics Price Target to $20 From $18, Maintains Buy Rating MT
Raymond James Downgrades AngioDynamics to Outperform From Strong Buy, Trims Price Target to $13 From $14 MT
Raymond James Adjusts Price Target on AngioDynamics to $14 From $22, Maintains Strong Buy Rating MT
Raymond James Adjusts AngioDynamics' Price Target to $22 From $25, Keeps Strong Buy Rating MT
Raymond James Adjusts AngioDynamics' Price Target to $25 from $27, Maintains Strong Buy Rating MT
Raymond James Adjusts AngioDynamics' Price Target to $27 from $32, Keeps Strong Buy Rating MT
ANGIODYNAMICS : Canaccord Genuity Upgrades AngioDynamics to Buy From Hold, Lifts Price Target to $37 From $28 MT
ANGIODYNAMICS : Oppenheimer Initiates Coverage on AngioDynamics With Perform Rating MT
ANGIODYNAMICS : Canaccord Genuity Adjusts Price Target on AngioDynamics to $28 From $24, Maintains Hold Rating MT
ANGIODYNAMICS : Raymond James Adjusts AngioDynamics' Price Target to $32 From $27, Keeps Strong Buy Rating MT
ANGIODYNAMICS : Raymond James Adjusts AngioDynamics' Price Target to $27 from $24, Keeps Strong Buy Rating MT
ANGIODYNAMICS : Canaccord Genuity Adjusts Price Target on AngioDynamics to $24 From $18, Maintains Hold Rating MT
ANGIODYNAMICS : Raymond James Upgrades AngioDynamics to Strong Buy From Market Perform; Price Target is $18 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.89 USD
Average target price
13.5 USD
Spread / Average Target
+129.20%
High Price Target
18 USD
Spread / Highest target
+205.60%
Low Price Target
10 USD
Spread / Lowest Target
+69.78%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AngioDynamics, Inc.

Oppenheimer
Raymond James
HC Wainwright
Canaccord Genuity

Ratings for AngioDynamics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ANGO Stock
  4. Consensus AngioDynamics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW